Wealth Enhancement Advisory Services, LLC Organogenesis Holdings Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $55.6 Billion
- Q2 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 34,323 shares of ORGO stock, worth $155,483. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,323
Previous 43,398
20.91%
Holding current value
$155,483
Previous $187,000
33.16%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ORGO
# of Institutions
125Shares Held
72MCall Options Held
15.1KPut Options Held
25-
Soleus Capital Management, L.P. Greenwich, CT12.3MShares$55.9 Million3.5% of portfolio
-
Morgan Stanley New York, NY12.1MShares$54.6 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN6.78MShares$30.7 Million3.81% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.2MShares$23.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$23 Million0.0% of portfolio
About Organogenesis Holdings Inc.
- Ticker ORGO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 130,888,000
- Market Cap $593M
- Description
- Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...